THQM logo

Tchaikapharma High Quality Medicines AD Stock Price

BUL:THQM Community·€693.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

THQM Share Price Performance

€7.35
-0.84 (-10.21%)
€7.35
-0.84 (-10.21%)
Price €7.35

THQM Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with questionable track record.

1 Risk
0 Rewards

Tchaikapharma High Quality Medicines AD Key Details

€36.4m

Revenue

€4.8m

Cost of Revenue

€31.6m

Gross Profit

€28.5m

Other Expenses

€3.1m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
0.031
86.77%
8.54%
7.2%
View Full Analysis

About THQM

Founded
1999
Employees
214
CEO
Biser Georgiev
WebsiteView website
www.tchaikapharma.com

Tchaikapharma High Quality Medicines AD develops, manufactures, and sells medicines in Bulgaria. It offers anaesthesia, anti-inflammatory and anti-rheumatic, antibiotics, cardiovascular system, digestive system, diabetes and metabolism, nervous system, over-the-counter, respiratory system, oncology, and other medicines. The company was founded in 1999 and is headquartered in Sofia, Bulgaria. Tchaikapharma High Quality Medicines AD operates as a subsidiary of Commercial League Healthcare Group Inc.

Recent THQM News & Updates

Analysis Article Apr 24

Here's Why We Think Tchaikapharma High Quality Medicines AD (BUL:THQM) Is Well Worth Watching

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Recent updates

No updates

Tchaikapharma High Quality Medicines AD Competitors